Results 191 to 200 of about 12,817 (217)

Mutations in the NS5A region of HCV and interferon efficacy

Gastroenterology, 1998
C, Sato, N, Enomoto
openaire   +2 more sources

Natural prevalence of NS5A polymorphisms in subjects infected with hepatitis C virus genotype 3 and their effects on the antiviral activity of NS5A inhibitors

Journal of Clinical Virology, 2013
Nannan Zhou
exaly  

HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis

Oncogene, 2002
Meei-Ling Sheu, Shou-Dong Lee, Keng-Hsin Lan   +2 more
exaly  

Inhibition of hepatitis C virus infection by NS5A-specific aptamer

Antiviral Research, 2014
Haizhen Zhu, Li Xu, Nianli Liu
exaly  

Systematic Identification of Hepatocellular Proteins Interacting with NS5A of the Hepatitis C Virus

BMB Reports, 2004
Suhn-Kee Chae, Jiwon Ahn, Kwang-Lae Hoe   +2 more
exaly  

O059 : Long-term persistence of HCV NS5A variants after treatment with NS5A inhibitor ledipasvir

Journal of Hepatology, 2015
H. Dvory-Sobol, D. Wyles, W. Ouyang, K. Chodavarapu, J. McNally, W. Cheng, S. Shafran, A. Mangia, C. Schwabe, M.D. Miller, H. Mo   +10 more
openaire   +1 more source

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir

Antimicrobial Agents and Chemotherapy, 2017
Michelle Irvin, John Randolph, Teresa Ng   +2 more
exaly  

Inhibitors of HCV NS5A

2010
LI LEPING, ZHONG MIN
openaire   +9 more sources

NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome

Journal of Hepatology, 2017
Wan-Long Chuang, Mark Sulkowski, Alessandra Mangia   +2 more
exaly  

Prevalence and Characterization of NS5A Resistance Associated Variants in Patients who Relapsed following Exposure to NS5A Inhibitors

Journal of Hepatology, 2016
P. Halfon, C. Scholtès, S. Mohamed, G. Penaranda, V. Leroy, M. Bourlière, D. Ouzan, L. Polverel, M.-A. Thélu, F. Zoulim, H. Khiri, S. Larrat   +11 more
openaire   +1 more source